Preferred Label : tumor necrosis factor;

Details


Main resources

You can consult :


https://www.cochrane.org/fr/CD013614/CENTRALED_quels-sont-les-benefices-et-risques-des-inhibiteurs-du-tnf-chez-les-personnes-atteintes-de
2025
United Kingdom
review of literature
french abstract
psoriasis, nos
arthritis
disease
risk assessment
polyarthritis
Polyarthritis
psoriasis
risks and benefits
tumor necrosis factor
persons
Tumor Necrosis Factor Inhibitors
anti-TNF

---
https://www.cochrane.org/fr/CD013715/CENTRALED_quels-sont-les-benefices-et-les-risques-des-inhibiteurs-du-facteur-de-necrose-tumorale-pour
2025
United Kingdom
review of literature
french abstract
rheumatoid arthritis, systemic juvenile
risk factors
arthritis, nos
unknown (origin)
risk factor
arthritis, juvenile
Tumor Necrosis Factor Inhibitors
risk assessment
risks and benefits
tumor necrosis factor

---
https://www.chu-lyon.fr/trouble-neurologique-fonctionnel-tnf
2024
France
popular works
nervous system diseases
tumor necrosis factor
neurology
tumor necrosis factors
functional disorder, nos

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety or Other Trial Information Documentation
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
Pregnant People
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida

---
https://www.rheuma-net.ch/fr/doc/anti-tnf/viewdocument/357
2024
Switzerland
guideline
Tumor Necrosis Factor Inhibitors
anti-TNF
Anti-Tumor Necrosis Factor Therapy
Background Treatment
tumor necrosis factor

---
http://www.cri-net.com/fiches-pratiques-et-eSessions/dernieres-mises-a-jour/traitements-anti-tnfa-et-suivi-de-tolerance
2020
France
guideline
tumor necrosis factor
anti-TNF
tumor necrosis factors
has patient
case management

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.